ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,373, issued on Oct. 21, was assigned to Amgen Inc. (Thousand Oaks, Calif.).
"Azetidinyl-acetamides as CXCR7 inhibitors" was invented by Pingchen Fan (Hayward, Calif.), Christopher W. Lange (Hayward, Calif.), Rebecca M. Lui (Mountain View, Calif.), Darren J. McMurtrie (Vancouver, Canada), Ryan J. Scamp (Fremont, Calif.), Ju Yang (Palo Alto, Calif.), Yibin Zeng (Foster City, Calif.) and Penglie Zhang (Foster City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds having formula I,or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7, and treating diseases that are dependent, a...